The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1

Ovarian cancer (OC) is one of the most common malignancies of the female reproductive system. The miRNA miR-582-3p is associated with a variety of tumors, and the aim of this study was to investigate the role and mechanisms of miR-582-3p specifically in ovarian carcinogenesis and progression. Low ex...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tianyu Dai, Junhui Liang, Wei Liu, Yonghui Zou, Feifei Niu, Mengqing Li, Haomeng Zhang, Changzhong Li, Mingjun Fan, Guoying Cui
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/0ef39530e11c4874ad16bd1bb1bfb80e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0ef39530e11c4874ad16bd1bb1bfb80e
record_format dspace
spelling oai:doaj.org-article:0ef39530e11c4874ad16bd1bb1bfb80e2021-11-26T11:19:49ZThe MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG12165-59792165-598710.1080/21655979.2021.2003662https://doaj.org/article/0ef39530e11c4874ad16bd1bb1bfb80e2021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2003662https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Ovarian cancer (OC) is one of the most common malignancies of the female reproductive system. The miRNA miR-582-3p is associated with a variety of tumors, and the aim of this study was to investigate the role and mechanisms of miR-582-3p specifically in ovarian carcinogenesis and progression. Low expression of miR-582-3p was noted in OC tissue and cell lines, and lower expression of miR-582-3p correlated with lower overall survival in OC patients. Knockdown of miR-582-3p promoted the proliferation and migration of OC cells, while overexpression inhibited them. TUG1, a long non-coding RNA, was found to bind to miR-582-3p, and inhibition of lncRNA TUG1 decreased viability and migration and weakened the effect of miR-582-3p knockdown in OC cells. Implantation of OC cells with reduced miR-582-3p caused increased tumor growth, while lncRNA TUG1 knockdown suppressed tumor growth and relieved the impact of reduced miR-582-3p in vivo. Phosphorylation of AKT and mTOR were significantly enhanced with decreased miR-582-3p expression, but lncRNA TUG1 knockdown attenuated this trend in vitro and in vivo. The novel miR-582-3p represses the malignant properties of OC via the AKT/mTOR signaling pathway by targeting lncRNA TUG1. This axis may represent valuable prognostic biomarkers and therapeutic targets for OC.Tianyu DaiJunhui LiangWei LiuYonghui ZouFeifei NiuMengqing LiHaomeng ZhangChangzhong LiMingjun FanGuoying CuiTaylor & Francis Grouparticlemir-582-3povarian cancerlncrna tug1akt/mtor signaling pathwayBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution DOAJ
collection DOAJ
language EN
topic mir-582-3p
ovarian cancer
lncrna tug1
akt/mtor signaling pathway
Biotechnology
TP248.13-248.65
spellingShingle mir-582-3p
ovarian cancer
lncrna tug1
akt/mtor signaling pathway
Biotechnology
TP248.13-248.65
Tianyu Dai
Junhui Liang
Wei Liu
Yonghui Zou
Feifei Niu
Mengqing Li
Haomeng Zhang
Changzhong Li
Mingjun Fan
Guoying Cui
The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
description Ovarian cancer (OC) is one of the most common malignancies of the female reproductive system. The miRNA miR-582-3p is associated with a variety of tumors, and the aim of this study was to investigate the role and mechanisms of miR-582-3p specifically in ovarian carcinogenesis and progression. Low expression of miR-582-3p was noted in OC tissue and cell lines, and lower expression of miR-582-3p correlated with lower overall survival in OC patients. Knockdown of miR-582-3p promoted the proliferation and migration of OC cells, while overexpression inhibited them. TUG1, a long non-coding RNA, was found to bind to miR-582-3p, and inhibition of lncRNA TUG1 decreased viability and migration and weakened the effect of miR-582-3p knockdown in OC cells. Implantation of OC cells with reduced miR-582-3p caused increased tumor growth, while lncRNA TUG1 knockdown suppressed tumor growth and relieved the impact of reduced miR-582-3p in vivo. Phosphorylation of AKT and mTOR were significantly enhanced with decreased miR-582-3p expression, but lncRNA TUG1 knockdown attenuated this trend in vitro and in vivo. The novel miR-582-3p represses the malignant properties of OC via the AKT/mTOR signaling pathway by targeting lncRNA TUG1. This axis may represent valuable prognostic biomarkers and therapeutic targets for OC.
format article
author Tianyu Dai
Junhui Liang
Wei Liu
Yonghui Zou
Feifei Niu
Mengqing Li
Haomeng Zhang
Changzhong Li
Mingjun Fan
Guoying Cui
author_facet Tianyu Dai
Junhui Liang
Wei Liu
Yonghui Zou
Feifei Niu
Mengqing Li
Haomeng Zhang
Changzhong Li
Mingjun Fan
Guoying Cui
author_sort Tianyu Dai
title The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
title_short The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
title_full The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
title_fullStr The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
title_full_unstemmed The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
title_sort mirna mir-582-3p suppresses ovarian cancer progression by targeting akt/mtor signaling via lncrna tug1
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/0ef39530e11c4874ad16bd1bb1bfb80e
work_keys_str_mv AT tianyudai themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT junhuiliang themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT weiliu themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT yonghuizou themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT feifeiniu themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT mengqingli themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT haomengzhang themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT changzhongli themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT mingjunfan themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT guoyingcui themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT tianyudai mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT junhuiliang mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT weiliu mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT yonghuizou mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT feifeiniu mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT mengqingli mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT haomengzhang mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT changzhongli mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT mingjunfan mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
AT guoyingcui mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1
_version_ 1718409451819499520